Octarine Bio
PrivateLast Round
Series A
Jan 22, 2026
Total Funding Raised
$22.9M
Momentum Score
50 /100
Company Overview
Octarine Bio is a biotechnology company focused on developing cannabinoids and psilocybin derivatives to enhance health and well-being through innovative biosynthetic solutions for treating neurological and psychological disorders.
Sector
Energy & Sustainability
Verticals
Biotechnology, Sustainable Materials, Fashion & Beauty, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Octarine Bio Comps
Public and private peers based on sector, stage, and business model.
Octarine Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 22, 2026 | ||||
| Series A | Nov 8, 2023 | ||||
| VC Round | Sep 20, 2022 | ||||
| Seed | Mar 11, 2021 | ||||
| Seed | Nov 12, 2020 | ||||
Pre Seed | Jan 10, 2020 |
Key People
Founding team and executive leadership
Octarine Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Edaphon | Series A |
| Unconventional Ventures | Series A |
| The Footprint Firm | Series A |
| Óskare Capital | Series A |
| The Export and Investment Fund of Denmark | Seed |
| DSM Venturing | VC Round |
| DSM-Firmenich Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 22, 2026
$15.3M round completed.
Octarine Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Octarine Bio's valuation, stock price, and market status.
